These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6512496)

  • 1. Radioimmunoassay for serum thyroglobulin designed for early detection of metastases and recurrencies in the follow-up of patients with differentiated thyroid carcinoma.
    Falk U; Schmidt-Gayk H; Hüfner M
    J Clin Chem Clin Biochem; 1984 Oct; 22(10):661-70. PubMed ID: 6512496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of [131I]- and [125I]human thyroglobulin labels for radioimmunoassay use.
    Schlumberger M; Van Herle AJ
    J Clin Endocrinol Metab; 1982 Mar; 54(3):581-6. PubMed ID: 7056843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
    Herle AJ; Uller RP
    J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
    Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
    Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of serum thyroglobulin measurements and whole body 131I scanning in the management of treated differentiated thyroid carcinoma.
    Galligan JP; Winship J; van Doorn T; Mortimer RH
    Aust N Z J Med; 1982 Aug; 12(4):248-54. PubMed ID: 6814409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
    Crane MS; Strachan MW; Toft AD; Beckett GJ
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyroglobulin in differentiated thyroid carcinoma.
    Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
    Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC; Sundram FX; Sin AE
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.
    Schlumberger M; Hitzel A; Toubert ME; Corone C; Troalen F; Schlageter MH; Claustrat F; Koscielny S; Taieb D; Toubeau M; Bonichon F; Borson-Chazot F; Leenhardt L; Schvartz C; Dejax C; Brenot-Rossi I; Torlontano M; Tenenbaum F; Bardet S; Bussière F; Girard JJ; Morel O; Schneegans O; Schlienger JL; Prost A; So D; Archambeaud F; Ricard M; Benhamou E
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2487-95. PubMed ID: 17426102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of [125I]thyroglobulin tracer heterogeneity on serum Tg RIA measurement.
    Spencer CA; Platler BW; Nicoloff JT
    Clin Chim Acta; 1985 Dec; 153(2):105-15. PubMed ID: 4064340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
    Siddiqi A; Foley RR; Britton KE; Sibtain A; Plowman PN; Grossman AB; Monson JP; Besser GM
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):515-21. PubMed ID: 11678835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.